Hypertension Clinical Trial
Official title:
Technology-Enabled Remote Hypertension Management To Advance Health Equity
The primary objective of this study is to reliably estimate the difference in blood pressure control of a technology-enabled solution for blood pressure (BP) management over usual care. The study will also assess patient and provider satisfaction with the solution. Finally, the investigators will estimate the economic impact of the intervention in terms of resource utilization.
Status | Not yet recruiting |
Enrollment | 1500 |
Est. completion date | March 17, 2026 |
Est. primary completion date | September 17, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 100 Years |
Eligibility | Inclusion Criteria: - 18 years - 100 years - uncontrolled hypertension: as defined as SBP > 140 or DBP > 90 on 2 successive clinic visits Exclusion Criteria: - hearing impaired - visually impaired - cognitively impaired - hospice care - on hemodialysis at enrollment - New York Heart Association Class IV heart failure |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Atman Health, Inc |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Home measured change in SBP and DBP | Home measured change in blood pressure in intervention group - more accurately measured: overall and by patient group | 6 months | |
Other | Patient satisfaction | A patient satisfaction survey with questions similar to the Consumer Assessment of Healthcare Providers and Systems will be used. | 6 months | |
Other | Provider satisfaction | A survey instrument will be developed and administered to assess provider satisfaction with having a remote team manage their patients. | 6 months | |
Other | Mean time required per patient for provider | Cumulative time in minutes for all interactions, including documentation. | 6 months | |
Other | Mean time required per patient for navigator | Cumulative time in minutes for all interactions, including documentation. | 6 months | |
Other | Proportion of patients measuring blood pressure at directed frequency | Proportion of patients measuring blood pressure at least twice a day during active management period. | 6 months | |
Other | Resource utilization | Difference in resource utilization between intervention and usual care for different patient groups using claims data. | 18 months | |
Primary | Difference in SBP change | Difference in mean change in systolic blood pressure (SBP) | 6 months after enrollment | |
Secondary | HEDIS proportion | Difference in the proportion of patients meeting HEDIS definition of controlled hypertension (SBP < 140 AND DBP < 90) between intervention and usual care: overall and by patient group and by age, race, sex strata | 6 months after enrollment | |
Secondary | Difference in DBP change | Difference in mean change in diastolic blood pressure (DBP) | 6 months after enrollment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |